Pharmaceutical industry news

Cullinan Therapeutics, Inc. - Common Stock (CGEM) Stock Price, News, Quote & History

Samsung Biologics signs USD 262 million manufacturing agreement with European pharmaceutical company

IMUNON Enters Cooperative Research and Development

West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts

SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline

Family Medicine Graduate Student orientation

Major expansion of community mental health support across England

£343 million plan will open 159 NHS mental health centres in England, giving people earlier local su...

mRNA cancer vaccines’ biggest barriers to market

Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successes

Burning Rock Biotech Releases Q2 2026 Financial Results

UPDATE -- Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference

Biotech Pre-Market Movers: TNON, AEON Surge; COO, CDT Slide

Biovie seeks FDA meeting to plan Phase 3 trial for Parkinson’s drug candidate

Ανάκληση της παρτίδας 25F1670 του Ιατροτεχνολογικού προϊόντος Gloflon I.V. CATHETER WITH INJECTION VALVES & WINGS 20G 1.1 x 33mm

Cannara Biotech secures $58M credit facility with BMO and TD

Latest figures highlight ongoing Meningitis B risk for students

Freshers urged to get vaccinated with 2 doses before term starts.

Burning Rock Q2 revenue falls 9.3% to RMB134.7M

Are Health Insurers to Blame for Our Health System Problems?

What’s Driving Rising Health Premiums?

What Do We Get for the Cut Health Insurers Take?

Who Do We Trust to Decide What Health Care Gets Covered, and at What Price?

National flu and COVID-19 surveillance reports: 2026 to 2027 season

National influenza (flu) and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other s...

No treatment is approved for menstrual migraine. AbbVie’s drug cut migraine days in a trial.

AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

Fórum Estadão discute os principais desafios e avanços da oncologia no País; Interfarma participa

GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities

Unlocking Cell Surface Protein Research with Site-Specific Labelling

£19.75 million boost for collaborations between universities

Oncolytics Biotech Reports Preclinical Pelareorep Activity Maintained with RAS Inhibition

What I’ve Learned: Christoph Müller

Daesang expands into pharmaceutical-grade amino acids

An experimental cancer treatment combination reduced tumor growth in early tests

An investigational cell therapy for Alzheimer’s and Parkinson’s will be presented in Korea.

A look at CleanAssure by Freudenberg Medical

White Is More Than a Color: How Nature Inspired a New Sustainable Way to Make White, Water-Repellent Materials

Dead or alive, plankton support marine ecosystems

IMN Screws System Advanced Locking Screw

Following a product complaint, and as part of its standard quality process, Stryker confirmed that o...

Generic acetaminophen by Teva recalled because it may contain foreign material

Teva Canada Limited is recalling one lot of the non-prescription drug Novo-Gesic Forte 500 mg (aceta...

Dxc 500i Clinical Analyzer and Dxc 500 AU Clinical Chemistry Analyzer

Beckman Coulter identified a software issue affecting DxC 500i and DxC 500 AU Analyzers when testing...

Centricity High Acuity Anesthesia

GE Healthcare has become aware of two potential issues associated with certain Centricity High Acuit...

Data on five-year remission with a myeloma treatment will be presented in Scotland

Frazier Life Sciences Adds Over $1.1 Billion to Frazier Life Sciences Public Fund

Why is Biohaven Pharmaceutical stock sliding today?

A booming business on Wall Street would love more biotechs to quietly die

EyePoint updates DURAVYU Phase 3 wet AMD data

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Ανάκληση της παρτίδας 3145507 του ιατροτεχνολογικού προϊόντος HIPPOKRATIS Επιθέματα γάζας μη αποστειρωμένα 10X20 PLY, REF: 1020121301

Biotech hair brand Vegamour snapped up by KVD Beauty owner Belle Brands

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Burning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness

Von Arzneimitteltherapiesicherheit bis zur Schmerzlinderung durch Virtuelle Realität: Universitätsklinikum Heidelberg lädt zum „Aktionstag Patientensicherheit“ ein

Burning Rock Biotech Reports Second Quarter 2026 Financial Results and Business Updates

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Can simulation help foundation trainee pharmacists prepare for prescribing?

Migraine and acne included in new prescribing Pharmacy First pathways

Uzbekistan Pharmaceutical Output Reaches UZS 3.5 Trillion in Seven Months

Phase 1/2 clinical trial of OPGx-BEST1 shows positive results for inherited retinal diseases

Podcast: key readouts from ESC and ERS

New suicide-risk research will join five posters on a treatment